MYCOPLASMA - ANVISA Registration 80263710029

Access comprehensive regulatory information for MYCOPLASMA in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80263710029 and manufactured by VIRCELL S.L.. The registration is held by VIRION DIAGNOSTICA LTDA with validity until Jan 24, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including EUROIMMUN AG, BIO-RAD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80263710029
2 Related Devices
Registration Details
ANVISA Registration Number: 80263710029
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

SPEED-OLIGO Mycoplasma pneumoniae
Risk Class III

Registration Details

80263710029

25351337744201076

04762623000152

Company Information

VIRCELL S.L.
Spain
PT: ESPANHA

Dates and Status

Jan 24, 2011

24/01/2026

09/18/2025 19:00:01

SPEED-OLIGO Mycoplasma pneumoniae
Risk Class III

Registration Details

80263710029

25351337744201076

04762623000152

Company Information

Dates and Status

Jan 24, 2011

24/01/2026

09/18/2025 19:00:01